From the Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, Essen, Germany.
Circ Res. 2015 Jul 17;117(3):279-88. doi: 10.1161/CIRCRESAHA.117.306878. Epub 2015 Jun 9.
Reduction of myocardial infarct size by remote ischemic preconditioning (RIPC), that is, cycles of ischemia/reperfusion in an organ remote from the heart before sustained myocardial ischemia/reperfusion, was confirmed in all species so far, including humans.
To identify myocardial signal transduction of cardioprotection by RIPC.
Anesthetized pigs were subjected to RIPC (4×5/5 minutes hindlimb ischemia/reperfusion) or placebo (PLA) before 60/180 minutes coronary occlusion/reperfusion. Phosphorylation of protein kinase B, extracellular signal-regulated kinase 1/2 (reperfusion injury salvage kinase [RISK] pathway), and signal transducer and activator of transcription 3 (survival activating factor enhancement [SAFE] pathway) in the area at risk was determined by Western blot. Wortmannin/U0126 or AG490 was used for pharmacological RISK or SAFE blockade, respectively. Plasma sampled after RIPC or PLA, respectively, was transferred to isolated bioassay rat hearts subjected to 30/120 minutes global ischemia/reperfusion. RIPC reduced infarct size in pigs to 16±11% versus 43±11% in PLA (% area at risk; mean±SD; P<0.05). RIPC increased the phosphorylation of signal transducer and activator of transcription 3 at early reperfusion, and AG490 abolished the protection, whereas RISK blockade did not. Signal transducer and activator of transcription 5 phosphorylation was decreased at early reperfusion in both RIPC and PLA. In isolated rat hearts, pig plasma taken after RIPC reduced infarct size (25±5% of ventricular mass versus 38±5% in PLA; P<0.05) and activated both RISK and SAFE. RISK or SAFE blockade abrogated this protection.
Cardioprotection by RIPC in pigs causally involves activation of signal transducer and activator of transcription 3 but not of RISK. Protection can be transferred with plasma from pigs to isolated rat hearts where activation of both RISK and SAFE is causally involved. The myocardial signal transduction of RIPC is the same as that of ischemic postconditioning.
远程缺血预处理(RIPC),即在持续心肌缺血/再灌注之前,对远离心脏的器官进行缺血/再灌注循环,可以减少心肌梗死面积,这在迄今为止所有物种(包括人类)中都得到了证实。
确定 RIPC 对心肌的保护信号转导作用。
在 60/180 分钟冠状动脉闭塞/再灌注之前,对麻醉猪进行 RIPC(4×5/5 分钟后肢缺血/再灌注)或安慰剂(PLA)处理。通过 Western blot 测定危险区的蛋白激酶 B、细胞外信号调节激酶 1/2(再灌注损伤挽救激酶[RISK]途径)和信号转导子和转录激活因子 3(存活激活因子增强[SAFE]途径)的磷酸化。分别用wortmannin/U0126 或 AG490 进行药理学 RISK 或 SAFE 阻断。分别取自 RIPC 或 PLA 后的血浆被转移到接受 30/120 分钟整体缺血/再灌注的分离生物测定大鼠心脏。RIPC 将猪的梗死面积减少到 16±11%,而 PLA 为 43±11%(危险区面积;平均值±标准差;P<0.05)。RIPC 增加了早期再灌注时信号转导子和转录激活因子 3 的磷酸化,而 AG490 则消除了这种保护作用,而 RISK 阻断则没有。在 RIPC 和 PLA 中,早期再灌注时信号转导子和转录激活因子 5 的磷酸化减少。在分离的大鼠心脏中,取自 RIPC 的猪血浆减少了梗死面积(心室质量的 25±5%,而 PLA 为 38±5%;P<0.05)并激活了 RISK 和 SAFE。RISK 或 SAFE 阻断消除了这种保护作用。
RIPC 在猪中的心脏保护作用涉及信号转导子和转录激活因子 3 的激活,但不涉及 RISK。可以用取自猪的血浆转移这种保护作用,而在分离的大鼠心脏中,RISK 和 SAFE 的激活是因果关系。RIPC 的心肌信号转导与缺血后处理相同。